Algorithm reconstructs lineages of competing cancer cells within individual tumours

May 30, 2014
Reconstruction of clonal heterogeneity. (A) Schematic view of subclonal diversification. In this example, mutations in daughter cells of a single founder cell (left) diverge into subclones (reflected by different colours). Two point mutations occur early on with a subsequent gain of a chromosome arm and a short deletion at a later stage, each followed by clonal expansion (subclones 1, 2, and 4). A short-lived lineage arises independently (subclone 3). (B) DNA sequencing of a cell population in a tumour sample and a matched normal can be used to infer the underlying population structure.

Researchers at the Wellcome Trust Sanger Institute have developed a method to characterise the main lineages of cells that are present in a tumour and their prevalence over time following chemotherapy. Aiming to reconstruct the genetic profiles of cellular lineages within the tumour, the team created a new computational algorithm named cloneHD which makes use of whole-genome DNA sequencing from mixed populations.

Cells in a tumour originate from a normal cell giving rise to billions of malignant, genetically diverse . Genome-wide approaches to study clonal heterogeneity are hampered by limited resolution of subpopulations, since short-read sequencing of mixed cell populations does not yield a direct readout of their clonal identity. There is mounting evidence for genetic heterogeneity in the majority of , which can translate in a differential response to treatment.

To address this problem, the uses short-read sequence data that can be related to different types of aberrations within all the genomes in a population to carry out its analysis. By combining these data the researchers can identify and describe the major lineages of genetically distinct cells, also known as clones. The algorithm classifies cells into groups, discriminating different that belong to each of the clonal lineages. At the genetic level, the algorithm can assign aberrations by clone: somatic changes to single letters and copy-number changes in the genetic code, as well as allelic imbalances in the germline caused by these events.

"Our cloneHD algorithm helps us generate useful insights into cancer development and the effects of treatment, by delineating cell lineages within the tumour and their progression over time." says Dr Ville Mustonen, senior author from the Sanger Institute.

To test that the algorithm can trace clonal dynamics in cancer, the researchers retrospectively explored temporal changes in a case study of a patient with chronic lymphocytic leukaemia, from whom sequence data had been collected at five different time points during the course of treatment. Such retrospective analysis is helpful to better understand tumour evolution. They further performed a mimic of real-time monitoring by progressively adding more samples to see if prospective analyses are of potential clinical relevance.

"The algorithm allowed us to see that the dominant lineage of diminished in response to treatment, but that another lineage of drug-resistant cells had started to rise in numbers," says Dr Andrej Fischer, first author from the Sanger Institute. "It is possible that, using this approach in conjunction with near real-time data collection, clinicians will be able to identify when a treatment is starting to fail."

In the near future, the team will test the algorithm and its potential clinical applications using larger data sets and a wider range of cancer types. Beyond cancer, a quantitative understanding of clonal dynamics translates to other organisms facing environmental stresses, such as bacteria, parasites or viruses.

Explore further: Scientists fingerprint single cancer cells to map cancer's family tree

More information: "High-definition reconstruction of clonal composition in cancer." Fischer A, Vázquez-García I, Illingworth CJR, Mustonen V. Cell Reports 2014. DOI: 10.1016/j.celrep.2014.04.055

Related Stories

Scientists fingerprint single cancer cells to map cancer's family tree

November 18, 2013
A new method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer's genetic diversity, new research reveals.

Researchers develop sequencing platform that generates "clinical-grade" data from small amounts of tumor sample DNA

May 19, 2014
(Medical Xpress)—A large team of researchers with members from several universities and hospitals in the U.S. has developed a sequencing platform that generates "clinical-grade" data using whole exome sequencing (WES) from ...

Rare genetic event massively predisposes people to a form of leukemia

March 23, 2014
Researchers have found that people born with a rare abnormality of their chromosomes have a 2,700-fold increased risk of a rare childhood leukaemia. In this abnormality, two specific chromosomes are fused together but become ...

Genetic tracking identifies cancer stem cells in human patients

May 15, 2014
The gene mutations driving cancer have been tracked for the first time in patients back to a distinct set of cells at the root of cancer – cancer stem cells. The international research team, led by scientists at the University ...

Scientists discover new route to boost pancreatic cancer treatment

May 30, 2014
Cancer Research UK scientists have uncovered new insights into how a key pancreatic cancer drug – gemcitabine – is broken down in tumour cells, according to research* published in the British Journal of Cancer (BJC), ...

Research brings significant improvement in genetic analysis of tumours

April 17, 2014
Every tumour is unique and requires specific treatment. A thorough and complete analysis of the genetic activity in the tumour cells is necessary to determine the appropriate treatment. Researchers at TU Delft, in collaboration ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.